Skip to main content

Table 1 Mechanisms of exosomes promoting angiogenesis

From: Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases

Source of exosomes

Intermediate molecule

Downstream pathway or molecule

Models or cells

Effect on downstream pathway

Refs.

Endothelial cell

miR-214

ATM

Endothelial cells

–

[29]

Adipose-derived MSCs

miR-125a

DLL4

Endothelial cells

–

[30]

Human umbilical cord derived MSC

NA

Wnt4/β-catenin

NA

 + 

[31]

Bone marrow derived MSCs

pSTAT3

NF-κB

NA

 + 

[32, 33]

Human term PlaMSCs

NA

Angiogenesis-related gene

In vivo murine auricle ischemic injury model

 + 

[34]

Human UCB

miR-21-3p

NA

Fibroblasts, endothelial cells

NA

[36]

Induced vascular progenitor cells

NA

NA

Rat hindlimb ischemia model

NA

[37]

Human EPC

NA

NA

H/R induction

NA

[38]

Hypoxic-induced MSC

NA

NA

NA

NA

[39, 40]

  1. 'NA' means no accessible data in the study.
  2. ATM, ataxia telangiectasia mutated; MSCs, mesenchymal stem cell; DLL4, Delta-like ligand4; PlaMSCs, placental tissue-derived MSCs; UCB, umbilical cord blood; EPC, endothelial progenitor cell; H/R, hypoxia/reoxygenation
  3. ' + ' represents the promotion of downstream pathway or molecule; '–' represents the inhibition of downstream pathway or molecule;